Article

Demystifying the Discussion of Sequencing Panel Size in Oncology Genetic Testing

2022-06-16

Abstract excerpt

Clinical laboratories worldwide are implementing next-generation sequencing (NGS) to identify cancer genomic variants and ultimately improve patient outcomes. The ability to massively sequence the entire genome or exome of tumour cells has been critical to elucidating many complex biological questions. However, the depth of information obtained by these methods is strenuous to process in the clinical setting, maki...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 68055550-6e83-5201-ba4b-a54c38927221
DOI: 10.33590/emj/22c9259

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Demystifying the Discussion of Sequencing Panel Size in Oncology Genetic TestingDOI 10.33590/emj/22c9259Read

Tumor Mutation Burden as a Cornerstone in Precision Oncology Landscapes: Effect of Panel Size and Uncertainty in Cutoffs.Semantic proximity Read

Tumor mutational burden quantification from targeted gene panels: major advancements and challengesSemantic proximity Read

Size matters: Dissecting key parameters for panel‐based tumor mutational burden analysisSemantic proximity Read

Integrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsSemantic proximity Read

Technical and implementation issues in using next-generation sequencing of cancers in clinical practice.Semantic proximity Read

Molecular profiling of solid tumors by next generation sequencing and challenges faced in the healthcare settingSemantic proximity Read

The clinical utility of molecular genetic cancer profiling.Semantic proximity Read

The relative utilities of genome-wide, gene panel, and individual gene sequencing in clinical practiceSemantic proximity Read

Panel Sequencing for Targeted Therapy Selection in Solid Tumors.Semantic proximity Read

Leveraging non-coding regions to guarantee the accuracy of small-sized panel-based tumor mutational burden estimates.Semantic proximity Read

Molecular Tumor Boards in Clinical Practice.Semantic proximity Read

Comparison of Large, Medium, and Small Solid Tumor Gene Panels for Detection of Clinically Actionable Mutations in Cancer.Semantic proximity Read